Xeljanz XR 11 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DR26F32UU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,749
Award facts
- Contract value 100% obligated
- $15,748.85 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $15,748.85 delivery order to AmerisourceBergen Drug Corp on June 29, 2026, for Xeljanz XR 11 mg tablets (30-count unit dose).
Place of performance is Conshohocken, PA. The order carries a firm fixed-price structure with an ultimate completion date of June 30, 2026. No set-aside was applied.
Quick answers
Who was awarded contract SPE2DR26F32UU?
SPE2DR26F32UU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 29, 2026.
How much is contract SPE2DR26F32UU worth?
The government has obligated $15,749 on SPE2DR26F32UU.
Is contract SPE2DR26F32UU an order under another contract?
Yes. SPE2DR26F32UU is a delivery order under SPE2DR25D3301, an indefinite delivery contract.
Was contract SPE2DR26F32UU competed?
The extent of competition for SPE2DR26F32UU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award